BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kwarteng A, Ahuno ST, Kwakye-Nuako G. The therapeutic landscape of HIV-1 via genome editing. AIDS Res Ther 2017;14:32. [PMID: 28705213 DOI: 10.1186/s12981-017-0157-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Soler Y, Rodriguez M, Austin D, Gineste C, Gelber C, El-Hage N. SERPIN-Derived Small Peptide (SP16) as a Potential Therapeutic Agent against HIV-Induced Inflammatory Molecules and Viral Replication in Cells of the Central Nervous System. Cells 2023;12. [PMID: 36831299 DOI: 10.3390/cells12040632] [Reference Citation Analysis]
2 Abana CZ, Lamptey H, Bonney EY, Kyei GB. HIV cure strategies: which ones are appropriate for Africa? Cell Mol Life Sci 2022;79:400. [PMID: 35794316 DOI: 10.1007/s00018-022-04421-z] [Reference Citation Analysis]
3 Borrajo A, Svicher V, Salpini R, Pellegrino M, Aquaro S. Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection. Microorganisms 2021;9:2537. [PMID: 34946138 DOI: 10.3390/microorganisms9122537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Sheykhhasan M, Foroutan A, Manoochehri H, Khoei SG, Poondla N, Saidijam M. Could gene therapy cure HIV? Life Sci 2021;277:119451. [PMID: 33811896 DOI: 10.1016/j.lfs.2021.119451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Howell EL, Yang S, Beets B, Brossard D, Scheufele DA, Xenos MA. What Do We (Not) Know About Global Views of Human Gene Editing? Insights and Blind Spots in the CRISPR Era. CRISPR J 2020;3:148-55. [PMID: 33560915 DOI: 10.1089/crispr.2020.0004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
6 Olson A, Basukala B, Lee S, Gagne M, Wong WW, Henderson AJ. Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9. Viruses 2020;12:E1154. [PMID: 33053801 DOI: 10.3390/v12101154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zhang N, Jing X, Liu Y, Chen M, Zhu X, Jiang J, Wang H, Li X, Hao P. Interfering with retrotransposition by two types of CRISPR effectors: Cas12a and Cas13a. Cell Discov 2020;6:30. [PMID: 34006868 DOI: 10.1038/s41421-020-0164-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Seif M, Einsele H, Löffler J. CAR T Cells Beyond Cancer: Hope for Immunomodulatory Therapy of Infectious Diseases. Front Immunol 2019;10:2711. [PMID: 31824500 DOI: 10.3389/fimmu.2019.02711] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 13.0] [Reference Citation Analysis]
9 El-Kenawy A, Benarba B, Neves AF, de Araujo TG, Tan BL, Gouri A. Gene surgery: Potential applications for human diseases. EXCLI J 2019;18:908-30. [PMID: 31762718 DOI: 10.17179/excli2019-1833] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Olson A, Basukala B, Wong WW, Henderson AJ. Targeting HIV-1 proviral transcription. Curr Opin Virol 2019;38:89-96. [PMID: 31473372 DOI: 10.1016/j.coviro.2019.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sadowski I, Hashemi FB. Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs. Cell Mol Life Sci 2019;76:3583-600. [PMID: 31129856 DOI: 10.1007/s00018-019-03156-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 14.5] [Reference Citation Analysis]
12 Skinner PJ. Targeting reservoirs of HIV replication in lymphoid follicles with cellular therapies to cure HIV. Adv Cell Gene Ther 2019;2:e27. [DOI: 10.1002/acg2.27] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Goryaev AA, Savkina MV, Mefed KM, Bondarev VP, Merkulov VA, Tarasov VV. Genome-Editing and Biomedical Cell Products: Current State, Safety and Efficacy. Biopreparaty Profilaktika, diagnostika, lechenie 2018;18:140-149. [DOI: 10.30895/2221-996x-2018-18-3-140-149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Kretova OV, Gorbacheva MA, Fedoseeva DM, Kravatsky YV, Chechetkin VR, Tchurikov NA. Mutation Frequencies in RNAi Targets in HIV-1 Genomes Obtained from Blood Plasma of Patients Receiving Anti-Retroviral Therapy. Mol Biol 2018;52:510-3. [DOI: 10.1134/s0026893318040118] [Reference Citation Analysis]
15 Masse-ranson G, Mouquet H, Di Santo JP. Humanized mouse models to study pathophysiology and treatment of HIV infection. Current Opinion in HIV and AIDS 2018;13:143-51. [DOI: 10.1097/coh.0000000000000440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
16 Hotter D, Kirchhoff F. Interferons and beyond: Induction of antiretroviral restriction factors. J Leukoc Biol 2018;103:465-77. [PMID: 29345347 DOI: 10.1002/JLB.3MR0717-307R] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
17 Ji C. Dissecting the Role of Disturbed ER-Golgi Trafficking in Antivirals and Alcohol Abuse-Induced Pathogenesis of Liver Disorders. J Drug Abuse 2017;3:14. [PMID: 29399658 DOI: 10.21767/2471-853X.100054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]